ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects

October 8, 1982

Tacoma Tests Of Two Patients Who Received Bahamas Treatment Are Positive For AIDS; Sera Contaminated

July 12, 1985

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

August 1, 1986

Cancer Meetings Listed For Next Three Months

June 25, 1993

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993